Publication | Open Access

Adalimumab for prevention of uveitic flare in patients with inactive non-infectious uveitis controlled by corticosteroids (VISUAL II): a multicentre, double-masked, randomised, placebo-controlled phase 3 trial

RheumatologyVisual IiInactive Non-infectious UveitisOcular DiseaseOphthalmologyClinical DermatologyUveitic FlareDermatologyImmunotherapyMedicineAllergic Rhinoconjunctivitis